Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status
34-year-old African American male with a diagnosis of schizophrenia was placed on aripiprazole and risperidone for psychosis and mood stabilization. Two days after medication initiation, the patient's mentation was altered and he appeared confused with an elevated creatine kinase (CK) at 7101....
Saved in:
Main Authors: | Amber N. Edinoff, Hamza Mohammad-Amin, Amira S. Odisho |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-08-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.37530 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone
by: Paras Agarwal, et al.
Published: (2021-01-01) -
Neuroleptic Malignant Syndrome: Diagnostic and Therapeutic Dilemmas
by: Abebaw Fekadu, et al.
Published: (2005-01-01) -
Constrictive Pericarditis Associated with Atypical Antipsychotics
by: Kuan-chin Jean Chen, et al.
Published: (2012-01-01) -
QT and QTc in Male Patients with Psychotic Disorders Treated with Atypical Neuroleptics
by: Mario Miniati, et al.
Published: (2017-01-01) -
Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01)